Lecap Asset Management Ltd. Invests $281,000 in Envista Holdings Co. (NYSE:NVST)

Lecap Asset Management Ltd. purchased a new position in Envista Holdings Co. (NYSE:NVST - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 14,555 shares of the company's stock, valued at approximately $281,000.

Several other hedge funds have also recently made changes to their positions in NVST. Mirae Asset Global Investments Co. Ltd. bought a new position in Envista in the 3rd quarter worth about $31,000. GAMMA Investing LLC lifted its position in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock worth $35,000 after purchasing an additional 726 shares during the period. Huntington National Bank lifted its position in shares of Envista by 97.8% in the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company's stock worth $38,000 after purchasing an additional 949 shares during the period. Blue Trust Inc. lifted its position in shares of Envista by 69.7% in the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock worth $39,000 after purchasing an additional 804 shares during the period. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock worth $43,000 after purchasing an additional 728 shares during the period.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on NVST shares. Leerink Partners raised shares of Envista from an "underperform" rating to a "market perform" rating and upped their price target for the stock from $16.00 to $23.00 in a research report on Thursday, October 31st. Needham & Company LLC reissued a "hold" rating on shares of Envista in a research report on Thursday, February 6th. Leerink Partnrs raised shares of Envista from a "strong sell" rating to a "hold" rating in a research report on Thursday, October 31st. Wells Fargo & Company increased their target price on shares of Envista from $20.00 to $21.00 and gave the company an "equal weight" rating in a research report on Thursday, February 6th. Finally, Robert W. Baird increased their target price on shares of Envista from $17.00 to $22.00 and gave the company a "neutral" rating in a research report on Thursday, October 31st. Two analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, Envista currently has a consensus rating of "Hold" and a consensus price target of $20.21.

Envista Stock Performance

Shares of NYSE:NVST traded down $0.16 during midday trading on Wednesday, reaching $20.86. The company's stock had a trading volume of 1,346,365 shares, compared to its average volume of 2,233,724. The firm has a market capitalization of $3.59 billion, a PE ratio of -3.21, a P/E/G ratio of 2.06 and a beta of 1.34. The company has a quick ratio of 1.77, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. The stock has a fifty day moving average of $19.90 and a 200 day moving average of $19.26. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $23.06.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, equities analysts expect that Envista Holdings Co. will post 1.06 EPS for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.